Stock BCT BRIACELL THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BriaCell Therapeutics Corp.

Equities

BCT

CA1079301091

Market Closed - Toronto S.E.
Other stock markets
 03:59:51 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.29 CAD +7.01% Intraday chart for BriaCell Therapeutics Corp. +16.24% -70.64%
May. 30 BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer MT
May. 30 BriaCell Therapeutics Corp. Initiates Patient Enrollment in First-In-Human Study of Bria-Ots in Advanced Metastatic Breast Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BRIACELL THERAPEUTICS CORP. Stock BriaCell Therapeutics Corp.
 30.69M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. BCT Stock
  4. Charts BriaCell Therapeutics Corp.
  5. Sector Chart